Meghmani Organics has announced that the audio recording of its Q4 FY26 earnings conference call is now available. The call was held on Saturday, May 16, 2026, at 11:00 AM IST to discuss the financial results for the quarter ended March 31, 2026. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Recording

The company has provided the link to access the audio recording of the proceedings. Investors and stakeholders can listen to the discussion regarding the quarterly performance by accessing the file hosted on the official website.

Key Participants

The conference call featured senior management representatives from Meghmani Organics, including the Chairman and Managing Director, the Chief Financial Officer, and the Investor Relations head. The session was facilitated by Arihant Capital Markets Ltd.

The filing was signed by Jayesh Patel, Company Secretary & Compliance Officer, on behalf of Meghmani Organics Limited.

Meghmani Organics Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported a significant improvement in standalone performance for the full year, while consolidated results returned to profitability. The company also released its investor presentation for Q4 FY26 on May 14, 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015.

Standalone Financial Performance

For the financial year ended March 31, 2026, standalone revenue from operations rose to Rs. 2,091.8 crore from Rs. 2,003.9 crore in FY25, up 4% year-on-year. EBITDA grew by 27% year-on-year to Rs. 228.7 crore, compared to Rs. 180.3 crore in the previous year, with an EBITDA margin of 10.9% versus 9.0% in FY25. Net profit for the year increased by 89% to Rs. 125.3 crore compared to Rs. 66.4 crore in FY25, with a net profit margin of 6.0%.

For the quarter ended March 31, 2026, standalone revenue stood at Rs. 456.6 crore, down 9% year-on-year from Rs. 502.1 crore in Q4 FY25. EBITDA for Q4 FY26 was Rs. 26.2 crore compared to Rs. 64.6 crore in Q4 FY25, a decline of 59% year-on-year, with EBITDA margin contracting to 5.7% from 12.9%. Standalone net profit for Q4 FY26 stood at Rs. 19.5 crore versus Rs. 34.0 crore in Q4 FY25. The company noted that subdued demand due to macroeconomic uncertainties impacted export volumes, while rising input costs and broadly stable realisations placed pressure on margins and profitability.

Consolidated Financial Performance

On a consolidated basis, Meghmani Organics recorded a turnaround in net profit, reporting Rs. 28.7 crore for FY26 against a net loss of Rs. 10.6 crore in FY25. Consolidated revenue from operations grew to Rs. 2,173.9 crore in FY26 from Rs. 2,079.7 crore in FY25. Total consolidated income for FY26 was Rs. 2,270.4 crore, up from Rs. 2,123.6 crore in FY25. For Q4 FY26, consolidated net profit was Rs. 8.0 crore, compared to Rs. 19.8 crore in Q4 FY25.

Segment Performance

Crop Protection constituted approximately 78% of the overall company's revenue in FY26. Revenue and EBITDA for the segment stood at Rs. 1,631.2 crore and Rs. 243.6 crore respectively, with an EBITDA margin of 14.9%. Capacity utilisation for this segment stood at 72%. The company has a global presence across 75+ countries, with 45% of demand coming from the US and Brazil, and serves 400+ marquee customers. The company is also setting up a subsidiary in Brazil to cater to that market and a representative office in China. Pan-India, it reaches approximately 10 million farmers through a network of 3,500+ distributors and dealers across 19 states.

The Pigments segment constituted approximately 22% of the overall revenue. Revenue and EBITDA stood at Rs. 460.6 crore and Rs. 15.0 crore respectively, with an EBITDA margin of 3.3%. Capacity utilisation for the Pigments segment was 40%, with 90% of business coming from repeat clients. The company temporarily suspended operations in Titanium Dioxide (TiO2) due to commercial unviability arising from elevated raw material costs and weaker price realisations following the withdrawal of anti-dumping duty.

Management Commentary

Commenting on FY26 performance, Mr. Ankit Patel, Chairman & Managing Director, said: "The financial year began on a positive note with overall demand improving gradually. However, from the second half of FY26, export volumes came under pressure due to subdued demand amid macroeconomic uncertainties including US tariff and geopolitical headwinds. These external factors also led to higher input costs, while realisation remained broadly stable placing pressure on margins and profitability. In our Crop Nutrition segment, we have further strengthened our product portfolio with the addition of three new nano fertilizer products namely Nano DAP, Nano NPK and Nano Zinc. We will be manufacturing these products at our Sanand manufacturing facility in Gujarat, leveraging our existing infrastructure with no additional capital expenditure. In Titanium Dioxide (TiO2), operations have been temporarily suspended due to commercial unviability arising from elevated raw material costs and weaker price realisations following the withdrawal of anti-dumping duty."

Shareholder & Market Information

As per the investor presentation, the company's share price stood at ₹36.74 with a market capitalisation of ₹934 crore as on March 30, 2026. The promoter holding stood at 48.95%, while public shareholding was at 49.01%. The free float market cap was ₹477 crore, with 25.4 crore shares outstanding.

Proposed Scheme of Amalgamation

The Board of Directors approved a Scheme of Amalgamation under Sections 230 to 232 of the Companies Act, 2013. The scheme involves the merger of two wholly owned subsidiaries — Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited — with Meghmani Organics Limited as part of an internal reorganisation. The key rationale includes simplification of group structure into a single listed entity, optimal utilisation of existing resources, operational and financial synergies, and stronger market positioning under a single brand identity. The appointed date is January 1, 2026, and no consideration or issue of shares is contemplated.